Inclusion Criteria:  FAC group: patients with familial familial amyloidotic cardiomyopathy (FAC). Non-FAC group: patients with transthyretin gene mutations who do not have FAC. Control group: healthy, asymptomatic individuals without comorbidities and without transthyretin gene mutations. Agreement and signing the informed consent form.  Exclusion Criteria:  -